AcetylcysteineLack of efficacy and off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1900卷 / 1期

关键词：

D O I：

10.1007/s40278-022-12368-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：16 / 16

相关论文

共 50 条

[1] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1866 (1) : 47 - 47
[2] BevacizumabLack of efficacy and off-label use: case report
Reactions Weekly, 2025, 2042 (1) : 81 - 81
[3] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1838 (1) : 56 - 56
[4] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 178 - 178
[5] HydroxychloroquineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 264 - 264
[6] AzithromycinLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1878 (1) : 110 - 110
[7] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 84 - 84
[8] NivolumabLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1945 (1) : 417 - 417
[9] FavipiravirLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1980 (1) : 175 - 175
[10] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 44 - 44

← 1 2 3 4 5 →